Hear other's experiences of natalizumab

	Caroline Diagnosed 7 years before interview. Taking natalizumab for 5 years.
	Caroline initially took Tysabri as part of a clinical trial, starting on it when the drug was still unlicensed. She took a break in treatment for a year and a half because the drug was unavailable during this time. It is now widely available.
	Caroline talks about her decision to start on natalizumab (Tysabri®) 2 min 41
	Caroline talks about the practicalities of having the infusion 2 min 06	Audio Player requires Flash 6 and Javascript
	Caroline talks about sources of information on natalizumab 30 secs	Audio Player requires Flash 6 and Javascript

	Mary Diagnosed 4 years before interview. Taking natalizumab for 2 years.
	Mary talks about her decision to start on natalizumab (Tysabri®) 4 min 16	Audio Player requires Flash 6 and Javascript
	Mary talks about the practicalities of having the infusion and the immediate effects 1 min 36	Audio Player requires Flash 6 and Javascript
	Mary on how natalizumab affects her 59 secs	Audio Player requires Flash 6 and Javascript
	Mary suggests advice to others considering the drug 1 min 46	Audio Player requires Flash 6 and Javascript

	Stephen Diagnosed 7 years before interview. Taking natalizumab for 2 years.
	Stephen talks about his decision to start on natalizumab (Tysabri®) 2 min 17	Audio Player requires Flash 6 and Javascript
	Stephen talks about the practicalities of having the infusion 1 min 43	Audio Player requires Flash 6 and Javascript
	Stephen talks about the effects of natalizumab and where to get more information 1 min 10	Audio Player requires Flash 6 and Javascript

Natalizumab